A.K. Webb

Andrew M. Jones

Aris

Biddick

Blackburn

Catherine J. Doherty

Chaparro

Coenye

Courtney

Davies

De Soyza

Ensor

Festini

Frangolias

Frederiksen

Garred

Govan

Hoiby

Isles

John R. Govan

Jones

Ledson

LiPuma

Mahenthiralingam

Mary E. Dodd

Megan W. France

Pankhurst

Saiman

Tablan

Taccetti

Vandamme

Vonberg

Yabuuchi

English

Background: This study reviews the impact of changing infection control practices at the Manchester Adult Cystic Fibrosis Centre (MACFC) upon the epidemiology of Burkholderia species infections.Methods: We reviewed strain and genomovar typing of all available Burkholderia isolates at our centre between 1983-2006.Results: The incidence/prevalence of infection with Burkholderia species between 1983-1990 was below 5%/9% each year. There was a rise in incidence/prevalence of Burkholderia species between 1991 and 1994 with a peak of 16.3%/31.2% in 1992. Following complete cohort segregation, the incidence has fallen to below 3% for all but one year and the prevalence has gradually reduced to 9.3% in 2005. Currently, there is all increase in the prevalence to 10.6% for the first time since 1994, predominantly due to patients with unique infections transferring into the unit from referring centres. The presence Of unique strains now exceeds transmissible strains for the first time since 1991.Conclusions: Infection control Measures including patient segregation have controlled spread of transmissible B. cenocepacia strains, but not the acquisition of unique strains. Unique Strains of Burkholderia species now account for the majority of new infections at the Manchester Adult Cystic Fibrosis Centre. Crown Copyright (C) 2008 Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society. All rights reserved.</p

France, Megan W.

Dodd, Mary E.

Govan, John R.

Doherty, Catherine J.

Webb, A. K.

Jones, Andrew M.

Edinburgh Research Explorer

Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis.

Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis. Thorax

Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cysticfibrosis. Lancet

Burkholderia cepacia in cystic fibrosis. Variable disease course.

Burkholderia cepacia: current clinical issues, environmental controversies and ethical dilemmas.

Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974–1995). Pediatr Pulmonol

Clinical follow-up of 122 Italian cystic fibrosis patients with B. cepacia complex colonisation. Cyst Fibros

Clinical outcome of Burkholderia cepacia complex infection in cystic fibrosis adults. Cyst Fibros

Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia. Thorax

DentonM.‘Cepaciasyndrome’with Burkholderia multivorans, 9 years after initial colonization. Cyst Fibros

Differential binding of mannose-bindinglectintorespiratorypathogensincysticfibrosis.Lancet2000

Diversity and role of Burkholderia spp.

Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet

Evidence of transmission of Burkholderia cepacia, Burkholderia multivorans and Burkholderia dolosa among persons with cystic fibrosis.

Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Infect Control Hosp Epidemiol

Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans. Clin Infect Dis

Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation. Am J Respir Crit Care Med

Is Burkholderia (Pseudomonas) cepacia disseminated from cystic fibrosis patients during physiotherapy? J Hosp Infect

Isolation measures for prevention of infection with respiratory pathogens in cystic fibrosis: a systematic review. J Hosp Infect

Isolation of infectious cystic fibrosis patients: results of a systematic review. Infect Control Hosp Epidemiol

JohansenHK.Isolation measuresfor preventionof infectionwith respiratory pathogens in cystic fibrosis: a systematic review? J Hosp Infect

Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type.

Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp.

Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre. Thorax

Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet

Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes

Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome.

Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.

Recovery of Burkholderia cenocepacia strain PHDC from cystic fibrosis patients in Europe. Thorax

Taxonomy and identification of the Burkholderia cepacia complex.

The Burkholderia cepacia complex — suggestions for prevention and infection control.

The environmental risk factors associated with medical and dental equipment in the transmission of Burkholderia (Pseudomonas) cepacia in cystic fibrosis patients. J Hosp Infect

Webb AK.Recent advances in cross-infection in cystic fibrosis: Burkholderia cepacia complex, Pseudomonas aeruginosa,

The changing epidemiology of Burkholderia species infection at an adult cystic fibrosis centre

Crossref

The changing epidemiology of Burkholderia species infection at an adult cystic fibrosis centre

Abstract

Similar works

Full text

Available Versions

Edinburgh Research Explorer

Crossref